BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 29258863)

  • 1. Fibrous cephalic plaques in tuberous sclerosis complex.
    Oyerinde O; Buccine D; Treichel A; Hong C; Lee CR; Moss J; Darling TN
    J Am Acad Dermatol; 2018 Apr; 78(4):717-724. PubMed ID: 29258863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of a fibrous cephalic plaque and sustained eight decade follow-up in an 80 year old with tuberous sclerosis complex type 2.
    Kirk CW; Donnelly DE; Hardy R; Shepherd CW; Morrison PJ
    Ulster Med J; 2020 Jan; 89(1):14-16. PubMed ID: 32218621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Characteristics of Connective Tissue Nevi in Tuberous Sclerosis Complex With Special Emphasis on Shagreen Patches.
    Bongiorno MA; Nathan N; Oyerinde O; Wang JA; Lee CR; Brown GT; Moss J; Darling TN
    JAMA Dermatol; 2017 Jul; 153(7):660-665. PubMed ID: 28445558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathological features of fibrous cephalic plaques in tuberous sclerosis complex.
    Treichel AM; Pithadia DJ; Lee CR; Oyerinde O; Moss J; Darling TN
    Histopathology; 2021 Oct; 79(4):619-628. PubMed ID: 33882161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncommon Large and Bilateral Fibrous Cephalic Plaques in a Patient with
    González-Del Angel A; Ruiz-Herrera A; Hernández-Martínez NL; Todd-Quiñones CG; Durán-McKinster C; Herrera-Mora P; Alcántara-Ortigoza MA
    Children (Basel); 2023 Sep; 10(10):. PubMed ID: 37892277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment of cutaneous manifestations of tuberous sclerosis complex with topical 1% sirolimus cream: A prospective study of 25 patients.
    Malissen N; Vergely L; Simon M; Roubertie A; Malinge MC; Bessis D
    J Am Acad Dermatol; 2017 Sep; 77(3):464-472.e3. PubMed ID: 28502378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous markers of systemic manifestations of tuberous sclerosis complex.
    Galahitiyawa J; Wanigasinghe J; Seneviratne J; Galahitiyawa M
    Int J Dermatol; 2015 Jan; 54(1):e52-5. PubMed ID: 25534411
    [No Abstract]   [Full Text] [Related]  

  • 8. Skin lesions in children with tuberous sclerosis complex: their prevalence, natural course, and diagnostic significance.
    Jóźwiak S; Schwartz RA; Janniger CK; Michałowicz R; Chmielik J
    Int J Dermatol; 1998 Dec; 37(12):911-7. PubMed ID: 9888331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis and association with tuberous sclerosis genes TSC1 and TSC2.
    Maruyama H; Ohbayashi C; Hino O; Tsutsumi M; Konishi Y
    Pathol Int; 2001 Aug; 51(8):585-94. PubMed ID: 11564212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrous cephalic plaques of the scalp.
    Arandes-Marcocci J; Iglesias-Sancho M; Melé-Ninot G; Setó-Torrent N; Fernández-Figueras MT; Salleras-Redonnet M
    Int J Dermatol; 2020 Feb; 59(2):e35-e37. PubMed ID: 31566268
    [No Abstract]   [Full Text] [Related]  

  • 11. Forehead plaque: a cutaneous marker of CNS involvement in tuberous sclerosis.
    Rama Rao GR; Krishna Rao PV; Gopal KV; Kumar YH; Ramachandra BV
    Indian J Dermatol Venereol Leprol; 2008; 74(1):28-31. PubMed ID: 18187819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome.
    Back SJ; Andronikou S; Kilborn T; Kaplan BS; Darge K
    Pediatr Radiol; 2015 Mar; 45(3):386-95. PubMed ID: 25355409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological Patterns of Skin Lesions in Tuberous Sclerosis Complex: A Panorama.
    Cascarino M; Leclerc-Mercier S
    Dermatopathology (Basel); 2021 Jul; 8(3):236-252. PubMed ID: 34287284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberous sclerosis complex: A clinical diagnosis in Ethiopian patients.
    Sisay B; Tadesse A; Gelaw A; Getahun D; Mulat B; Kebede W; Gebrewold Y
    Medicine (Baltimore); 2024 Feb; 103(6):e37135. PubMed ID: 38335392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of twenty pediatric cases of tuberous sclerosis complex: are we doing enough?
    Nath J; Dubey A; Pavan R
    Indian J Dermatol Venereol Leprol; 2015; 81(1):23-8. PubMed ID: 25566892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial differences in the dermatological manifestations of tuberous sclerosis complex and the potential effects on diagnosis and care.
    Pounders AJ; Rushing GV; Mahida S; Nonyane BAS; Thomas EA; Tameez RS; Gipson TT
    Ther Adv Rare Dis; 2022; 3():26330040221140125. PubMed ID: 37180419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cutaneous features of tuberous sclerosis: a population study.
    Webb DW; Clarke A; Fryer A; Osborne JP
    Br J Dermatol; 1996 Jul; 135(1):1-5. PubMed ID: 8776349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TuberOus SClerosis registry to increase disease Awareness (TOSCA) - baseline data on 2093 patients.
    Kingswood JC; d'Augères GB; Belousova E; Ferreira JC; Carter T; Castellana R; Cottin V; Curatolo P; Dahlin M; de Vries PJ; Feucht M; Fladrowski C; Gislimberti G; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Nabbout R; O'Callaghan F; Benedik MP; Qin J; Marques R; Sander V; Sauter M; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen AC;
    Orphanet J Rare Dis; 2017 Jan; 12(1):2. PubMed ID: 28057044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forehead plaque in a child with epilepsy: A clue for tuberous sclerosis.
    Singanamalla B; Bhagwat C; Madaan P; Saini L; De D
    Trop Doct; 2021 Apr; 51(2):259-260. PubMed ID: 33232218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Miliary fibromas in tuberous sclerosis complex.
    Cartron AM; Buccine D; Treichel AM; Lee CR; Moss J; Darling TN
    J Eur Acad Dermatol Venereol; 2021 May; 35(5):1226-1229. PubMed ID: 33565654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.